Brief: Astria Reports Positive Phase 1A STAR-0310 Trial Results At European Dermatology & Venereology Congress

Astria Therapeutics

17/09/2025 13:10

Sept 17 (Reuters) - Astria Therapeutics Inc ATXS.O:

ASTRIA THERAPEUTICS ANNOUNCES POSITIVE INITIAL RESULTS FROM THE PHASE 1A HEALTHY SUBJECT TRIAL OF STAR-0310 AT THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

ASTRIA THERAPEUTICS INC - STAR-0310 WELL-TOLERATED WITH NO ADCC-RELATED ADVERSE EVENTS

ASTRIA THERAPEUTICS INC - STAR-0310 SHOWS 68-DAY HALF-LIFE AND CYTOKINE SUPPRESSION

Source text: ID:nBw1gv2Kta

Further company coverage: ATXS.O

 ((Reuters.Briefs@thomsonreuters.com;))